ICD-10 Code C85.89
Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites
“Oth types of non-hodg lymph, extrnod and solid organ sites” for short
C85.89 is an International Classification of Diseases, Tenth Revision, code used to designate primary diagnoses of other specified types of non-Hodgkin lymphoma that manifest in extranodal and solid organ sites. Clinically, non-Hodgkin lymphoma comprises a heterogeneous group of malignant lymphoproliferative disorders originating from B-cells, T-cells, or natural killer cells. While these neoplasms typically arise within primary lymphoid tissues such as the lymph nodes, spleen, or bone marrow, code C85.89 specifically applies when a specified lymphoma subtype primarily infiltrates non-lymphoid organs or tissues outside the lymphatic system. Related conditions and diseases falling under or clinically associated with this code include extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue, primary cutaneous T-cell or B-cell lymphomas, primary central nervous system lymphoma, primary pulmonary lymphoma, primary gastrointestinal lymphoma, primary hepatic lymphoma, and other less common, well-defined extranodal B-cell or T-cell malignancies. Symptoms vary based on the organ system involved, ranging from localized masses, pain, or organ dysfunction to systemic B symptoms such as fever, night sweats, and unexplained weight loss, requiring tissue biopsy, immunohistochemistry, and advanced imaging for definitive diagnosis and staging.
C85.89 is a valid billable ICD-10 diagnosis code for Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites. It is found in the 2027 version of the ICD-10 CM Index and can be used in all HIPAA-covered transactions from Oct 01, 2026 - Sep 30, 2027.
See also, ICD-10 Table of Neoplasms.
- MDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms
Lymphoma and Leukemia with Major Procedure - MDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms
Lymphoma and Non-Acute Leukemia with Other Procedure - MDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms
Lymphoma and Non-Acute Leukemia - MDC 25 Human Immunodeficiency Virus Infections
HIV with Major Related Condition
ICD-10 code C85.89 is based on the following Tabular structure:
Chapter 2: Neoplasms- Section C81-C96: Malignant neoplasms of lymphoid, hematopoietic and related tissue
- Category C85: Other specified and unspecified types of non-Hodgkin lymphoma
↑ Parent code:
C85.8 for Other specified types of non-Hodgkin lymphoma
Should you use C85.89 or C8589 (with or without decimal point) when submitting claims?
DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you
but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically.
This note further define, or give examples of, the content of the code or category.
List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of “other specified” codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.
A type 1 Excludes note is a pure excludes. It means 'NOT CODED HERE!' An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
A type 2 Excludes note represents 'Not included here'. An Excludes2 note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When an Excludes2 note appears under a code it is acceptable to use both the code and the excluded code together.
A “code also” note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction. The sequencing depends on the circumstances of the encounter.
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.